WHO ICTRP trial
Pioglitazone in Acute Ischemic Stroke Trial
JPRN-UMIN000000699 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000000699 |
|---|---|
| Public title | Pioglitazone in Acute Ischemic Stroke Trial |
| Scientific title | Pioglitazone in Acute Ischemic Stroke Trial - Pioglitazone in Acute Ischemic Stroke Trial (PAIST) |
| Primary sponsor | Keio University School of Medicine Department of Neurology |
| Secondary sponsors | Department of Neurology, Tokyo Saiseikai Central Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Ischemic stroke |
| Interventions | Patients will be randomly selected to receive pioglitazone Patients will also be randomly selected to receive treatment with conventional therapy |
| Registration date | Dec 31, 2008 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: